ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate and Astrocytoma, Grade IV

ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hayashi, T; Imanaka, T; Iwashima, M; Kanai, M; Mizuno, S; Morita, M; Shimozawa, N; Suzuki, Y	1

Other Studies

1 other study(ies) available for ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate and Astrocytoma, Grade IV

Article	Year
Baicalein 5,6,7-trimethyl ether activates peroxisomal but not mitochondrial fatty acid beta-oxidation. Journal of inherited metabolic disease, 2008, Volume: 31, Issue:3 Topics: Adrenoleukodystrophy; ATP Binding Cassette Transporter, Subfamily D; ATP-Binding Cassette Transporters; Carnitine Acyltransferases; Cells, Cultured; Coenzyme A Ligases; Epoxy Compounds; Fatty Acids; Fibroblasts; Flavanones; Glioblastoma; Humans; Mitochondria; Oxidation-Reduction; Peroxisomes; Zellweger Syndrome	2008

Article

Year

Baicalein 5,6,7-trimethyl ether activates peroxisomal but not mitochondrial fatty acid beta-oxidation.

Journal of inherited metabolic disease, 2008, Volume: 31, Issue:3

Topics: Adrenoleukodystrophy; ATP Binding Cassette Transporter, Subfamily D; ATP-Binding Cassette Transporters; Carnitine Acyltransferases; Cells, Cultured; Coenzyme A Ligases; Epoxy Compounds; Fatty Acids; Fibroblasts; Flavanones; Glioblastoma; Humans; Mitochondria; Oxidation-Reduction; Peroxisomes; Zellweger Syndrome

2008